Skip to main content
Advertisement
Advertisement

NVNO

NVNO logo

enVVeno Medical Corporation Common Stock

9.02
USD
Sponsored
+0.23
+2.58%
Sep 18, 13:21 UTC -4
Open

NVNO Earnings Reports

Positive Surprise Ratio

NVNO beat 13 of 24 last estimates.

54%

Next Report

Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$3.33
Implied change from Q2 26 (Revenue/ EPS)
--
/
-37.99%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-58.63%

enVVeno Medical Corporation Common Stock earnings per share and revenue

On Jul 30, 2026, NVNO reported earnings of -5.37 USD per share (EPS) for Q2 26, missing the estimate of -4.78 USD, resulting in a -12.25% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.17% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -3.33 USD, with revenue projected to reach -- USD, implying an decrease of -37.99% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NANO-X IMAGING LTD Ordinary Shares
Report Date
Sep 09, 2026 For Q2 26
Estimate
-$0.16
Actual
-$0.80
Surprise
-380.19%
FAQ
For Q2 2026, enVVeno Medical Corporation Common Stock reported EPS of -$5.37, missing estimates by -12.25%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.17%, changed from $10.40 before the earnings release to $10.63 the day after.
The next earning report is scheduled for Oct 28, 2026.
Based on 3 analysts, enVVeno Medical Corporation Common Stock is expected to report EPS of -$3.33 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement